Anemia and survival in HIV infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 1, 1998, Pages 29-33

  Moore, Richard D ^a   Keruly, Jeanne C ^a   Chaisson, Richard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Erythropoietin; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; GANCICLOVIR; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RISK FACTOR; SURVIVAL;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032168057     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199809010-00004     Document Type: Article

References (22)

1. Moore RD, Keruly J, Richman DD, et al. Natural history of advanced HIV disease in patients treated with zidovudine. AIDS 1992;6:671-7.
2. Doukas MA. Human immunodeficiency virus associated anemia. Med Clin North Am 1992;76:699.
3. Zon LI, Arkin C, Groopman J. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haemotol 1987;66: 251.
4. Kaslow RA, Phair JP, Friedman HB, et al. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. Ann Intern Med 1987;107:474-80.
5. Swanson CE, Cooper DA. Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. AIDS 1990;4:749-57.
6. Steinberg JP, Spear JB, Murphy RL, et al. Predictors of outcome in AIDS patients receiving zidovudine. J Acquir Immune Defic Syndr 1989;2:229-34.
7. Creagh-Kirk T, Doi P, Andrews E, et al. Survival experience among patients with AIDS receiving zidovudine. JAMA 1988;260: 3009-15.
8. Easterbrook PJ, Keruly JC, Creagh-Kirk T, et al. Racial and ethnic differences in outcome in zidovudine treated patients with advanced HIV disease. JAMA 1991;266;2713-18.
9. Fischl MA, Richman DD, Causey DM, et al. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 1989;262:2405-10.
10. Swanson CE, Tindall B, Cooper DA. Efficacy of zidovudine treatment homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug tolerance. AIDS 1994;8:625-34.
11. Samuels JE, Hendrix J, Hilton M, et al. Zidovudine therapy in an inner city population. J Acquir Immune Defic Syndr 1990;3:877-83.
12. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward W. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998;91:301-8.
13. Sathe SS, Gascone P, Lo W, et al. Severe anemia is an important negative predictor for survival with disseminated Mycobacterium avium-intracellualare in acquired immunodeficiency syndrome. Am Rev Respir Dis 1990;142:1306-12.
14. Gallant JM, Moore RD, Richman DD, Keruly JC, Chaisson RE, and the ZDV Epidemiology Group. Incidence and natural history of cytomegalovirus disease in patients with advanced HIV disease treated with zidovudine. J Infect Dis 1992;166:1223-27.
15. Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488-93.
16. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Arch Intern Med 1993;153:2669-75.
17. Henry DH, Beall GN, Benson CA, et al. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Ann Intern Med 1992;117:739-48.
18. Revicki DA, Brown RE, Henry DH, et al. Recombinant human erythropoietin and health related quality of life of AIDS patients and anemia. J Acquir Immune Defic Syndr 1994;7:474-84.
19. Gascon P, Zoumbos NC, Young NS. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 1984;100:173-7.
20. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/ suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64:308-10.
21. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 1989;321:947-51.
22. Moore RD, Keruly JC, Chaisson RE. The effectiveness of combination antiretroviral therapy in clinical practice. Presented at the 35th Annual Meeting of the Infectious Diseases Society of America, San Francisco, September, 1997.